5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 20.86▼ | 20.75▲ | 20.71▲ | 19.86▲ | 16.70▲ |
MA10 | 20.89▼ | 20.65▲ | 20.71▲ | 17.96▲ | 18.29▲ |
MA20 | 20.82▼ | 20.64▲ | 20.37▲ | 16.35▲ | 19.01▲ |
MA50 | 20.66▲ | 19.96▲ | 18.86▲ | 18.54▲ | 15.10▲ |
MA100 | 20.66▲ | 18.61▲ | 16.85▲ | 19.00▲ | 12.48▲ |
MA200 | 20.38▲ | 16.62▲ | 17.31▲ | 16.45▲ | 17.93▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.012▼ | -0.028▼ | -0.069▼ | 0.817▲ | -0.473▼ |
RSI | 47.633▼ | 61.673▲ | 72.453▲ | 68.086▲ | 58.005▲ |
STOCH | 40.436 | 70.555 | 70.887 | 97.963▲ | 34.949 |
WILL %R | -88.889▼ | -35.294 | -19.200▲ | -3.053▲ | -36.591 |
CCI | -172.640▼ | 97.528 | 84.560 | 126.281▲ | 22.566 |
Friday, May 02, 2025 12:16 AM
Despite a significant increase in net sales, Travere Therapeutics Inc (TVTX) faces hurdles with a reported net loss and anticipated market competition.
|
Thursday, May 01, 2025 01:01 PM
Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its first quarter 2025 financial results and provided a corporate update.
|
Wednesday, April 30, 2025 12:03 PM
Shares of Travere Therapeutics were trading at $20.08 as of April 29. Over the last 52-week period, shares are up 236.04%. Given that these returns are generally positive, long-term shareholders are ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 20.735 | 21.00 | 20.31 | 20.76 | 1,917,128 |
30/04/25 | 19.70 | 20.91 | 19.69 | 20.81 | 1,514,352 |
29/04/25 | 19.34 | 20.085 | 19.30 | 20.06 | 980,450 |
28/04/25 | 18.36 | 19.49 | 18.145 | 19.36 | 2,369,513 |
25/04/25 | 17.29 | 18.45 | 17.29 | 18.33 | 1,323,140 |
24/04/25 | 16.76 | 17.685 | 16.76 | 17.63 | 1,426,068 |
23/04/25 | 16.23 | 17.54 | 16.185 | 16.70 | 1,684,449 |
22/04/25 | 15.33 | 16.08 | 15.33 | 15.88 | 1,277,968 |
21/04/25 | 14.73 | 15.87 | 14.71 | 15.11 | 1,149,246 |
17/04/25 | 14.56 | 15.00 | 14.56 | 14.92 | 1,101,182 |
|
|
||||
|
|
||||
|
|